Related Experiment Video
Updated: Jun 7, 2026
Mapping Infant Immunity with Minimal Input: Integrative Single-Cell and Multiomic Profiling
Published on: April 3, 2026
Toxicopathology of the developing immune system: investigative and development strategies
Daniel Weinstock1, David B Lewis, George A Parker
1Sanofi aventis, US Inc, Bridgewater, New Jersey 08807-0800, USA.
Abstract:
Developmental immunotoxicity (DIT) has gained attention with the recognition that environmental chemicals can potentially affect the developing immune system and the incidence of childhood allergic diseases. Preclinical safety assessment of pharmaceuticals for men and women of childbearing potential as well as for pediatric and juvenile indications may require DIT assessments. Draft documents from environmental and chemical regulatory agencies propose strategies that use the rat as a test species and incorporate histopathology and functional testing as endpoints. While there are no guidelines for DIT assessment of pharmaceuticals, current discussions suggest that combining immunotoxicity and developmental and reproductive toxicology studies may serve this purpose. Knowledge of the principles and applications of DIT will facilitate participation in strategy development and effective conduct of relevant studies.
Insights
Environmental chemicals can impact the developing immune system, increasing risks for childhood allergies. Developmental immunotoxicity (DIT) assessments are crucial for pharmaceutical safety in vulnerable populations.
Area of Science:
- Immunology
- Toxicology
- Developmental Biology
Background:
- Developmental immunotoxicity (DIT) is increasingly recognized for its potential to affect immune system development.
- Environmental chemicals are linked to the rising incidence of childhood allergic diseases.
- DIT assessments are becoming essential for preclinical pharmaceutical safety evaluations.
Framework:
- Regulatory agencies are proposing strategies for DIT assessment using rats.
- Proposed strategies incorporate histopathology and functional testing as key endpoints.
- Combining immunotoxicity with developmental and reproductive toxicology studies is suggested for DIT assessment.
Implementation:
- Pharmaceutical safety assessments for reproductive-aged individuals and pediatric/juvenile indications may necessitate DIT studies.
- While specific DIT guidelines for pharmaceuticals are absent, discussions are ongoing.
- Integrating DIT principles into existing toxicology frameworks is a focus.
Implications:
- Understanding DIT principles is vital for developing effective assessment strategies.
- Knowledge facilitates the accurate conduct of DIT studies.
- This research supports the safety evaluation of pharmaceuticals for diverse populations.
Related Concept Videos
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...